Agilent CEO to Retire with Successor Named

Details

announced that Michael McMullen, President and CEO, will retire on May 1, 2024, and continue as a senior advisor until October 31, 2024. Padraig McDonnell, currently Senior Vice President, has been appointed as COO and CEO-elect, effective March 1, 2024. The Compensation Committee approved changes to McDonnell's compensation package, including salary increase, performance-based compensation, and equity awards. The Board intends to appoint McDonnell as CEO and nominate him to the Board upon McMullen's retirement.

Items reported

Exhibits (1)

About Agilent Technologies Inc.

Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.